- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.18B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.15B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.52B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.49B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $140.55M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $150.93M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 24.09M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $41.08K |
| Capex | Q1 2025 · Mar 31, 2024 | $256.16K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $25.08M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $320.1M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $312.9M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.31 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.32 |
| Net Income | Q1 2025 · Mar 31, 2024 | $7.47M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.27M |
| Revenue | Q1 2025 · Mar 31, 2024 | $81.19M |